JP2011505810A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011505810A5 JP2011505810A5 JP2010537235A JP2010537235A JP2011505810A5 JP 2011505810 A5 JP2011505810 A5 JP 2011505810A5 JP 2010537235 A JP2010537235 A JP 2010537235A JP 2010537235 A JP2010537235 A JP 2010537235A JP 2011505810 A5 JP2011505810 A5 JP 2011505810A5
- Authority
- JP
- Japan
- Prior art keywords
- human
- fragment
- nucleotide sequence
- antibody
- humanized anti
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200710094456 CN101245108B (zh) | 2007-12-13 | 2007-12-13 | 抗人cd34抗体、其制备方法及用途 |
| CN200810043016 | 2008-01-08 | ||
| PCT/CN2008/001963 WO2009079922A1 (en) | 2007-12-13 | 2008-12-03 | Humanized anti-cd34 monoclonal antibody, the preparation and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011505810A JP2011505810A (ja) | 2011-03-03 |
| JP2011505810A5 true JP2011505810A5 (https=) | 2012-01-26 |
Family
ID=40800709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010537235A Ceased JP2011505810A (ja) | 2007-12-13 | 2008-12-03 | ヒト化抗ヒトｃｄ３４抗体、その調製方法および使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20100311955A1 (https=) |
| EP (1) | EP2233501B1 (https=) |
| JP (1) | JP2011505810A (https=) |
| BR (1) | BRPI0821211A2 (https=) |
| CA (1) | CA2708407A1 (https=) |
| WO (1) | WO2009079922A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2686418A4 (en) | 2011-03-17 | 2015-04-22 | Minerva Biotechnologies Corp | METHOD FOR THE PRODUCTION OF PLURIPOTENTAL STEM CELLS |
| US8785603B2 (en) | 2011-05-20 | 2014-07-22 | Siemens Healthcare Diagnostics Inc. | Antibodies to 25-hydroxyvitamin D2 and D3 and uses thereof |
| TWI443107B (zh) | 2011-12-29 | 2014-07-01 | Ind Tech Res Inst | 人源化之抗人類細胞表面抗原ｃｄ３４之單株抗體及其應用 |
| DK3105252T3 (da) | 2014-02-12 | 2019-10-14 | Michael Uhlin | Bispecifikke antistoffer til anvendelse ved stamcelletransplantation |
| US10604586B2 (en) | 2016-05-09 | 2020-03-31 | Industrial Technology Research Institute | Humanized monoclonal antibody and uses thereof |
| CN109265547B (zh) * | 2018-07-23 | 2022-07-26 | 中国科学院微生物研究所 | 一种抗cd47抗体及其应用 |
| CN111879923A (zh) * | 2020-08-06 | 2020-11-03 | 深圳科隆生物新材料有限公司 | 一种可消除hama效应的试剂盒 |
| WO2023133595A2 (en) | 2022-01-10 | 2023-07-13 | Sana Biotechnology, Inc. | Methods of ex vivo dosing and administration of lipid particles or viral vectors and related systems and uses |
| EP4466019A4 (en) * | 2022-01-21 | 2026-01-07 | Marengo Therapeutics Inc | MULTIFUNCTIONAL MOLECULES COMPRISING A G6B BINDER AND/OR A CD34 BINDER AND THEIR USES |
| WO2024040194A1 (en) | 2022-08-17 | 2024-02-22 | Capstan Therapeutics, Inc. | Conditioning for in vivo immune cell engineering |
| WO2024081820A1 (en) | 2022-10-13 | 2024-04-18 | Sana Biotechnology, Inc. | Viral particles targeting hematopoietic stem cells |
| WO2024119157A1 (en) | 2022-12-02 | 2024-06-06 | Sana Biotechnology, Inc. | Lipid particles with cofusogens and methods of producing and using the same |
| KR20260016952A (ko) | 2023-05-23 | 2026-02-04 | 사나 바이오테크놀로지, 인크. | 탠덤 퓨소젠 및 관련 지질 입자 |
| WO2025006799A1 (en) | 2023-06-27 | 2025-01-02 | Capstan Therapeutics, Inc. | Extracorporeal and ex vivo engineering of select cell populations from peripheral blood |
| CN116970650B (zh) * | 2023-09-22 | 2023-12-08 | 深圳华大生命科学研究院 | 一种包膜蛋白组合、含其的靶向病毒载体及制备方法 |
| WO2025184529A1 (en) | 2024-03-01 | 2025-09-04 | Sana Biotechnology, Inc. | Viral particles with fusogen display and related compositions and methods |
| CN118501458B (zh) * | 2024-05-08 | 2025-09-30 | 广东省第二人民医院（广东省卫生应急医院） | 一种外周血细胞外囊泡表面多种免疫标志物联合检测的试剂盒及方法 |
| CN120098129B (zh) * | 2025-03-03 | 2026-04-03 | 安徽医科大学第一附属医院 | 一种具有信号蛋白标签的cd34生物融合酶抗体及应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5530101A (en) * | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| JPH11332594A (ja) * | 1998-05-26 | 1999-12-07 | Asahi Chem Ind Co Ltd | Ｃｄ４陽性細胞の分離装置および分離方法 |
| JPH11332578A (ja) * | 1998-05-25 | 1999-12-07 | Asahi Chem Ind Co Ltd | 細胞の分離装置及び分離方法 |
| KR20010043797A (ko) * | 1998-05-25 | 2001-05-25 | 아사히 메디칼 가부시키가이샤 | 세포 분리 장치 및 분리 방법 |
| AU2001274931B2 (en) * | 2000-05-23 | 2006-03-30 | Nexell Therapeutics, Inc. | Reagents for cell selection and methods of use |
| US8728525B2 (en) * | 2004-05-12 | 2014-05-20 | Baxter International Inc. | Protein microspheres retaining pharmacokinetic and pharmacodynamic properties |
| CN101245108B (zh) * | 2007-12-13 | 2013-04-10 | 上海抗体药物国家工程研究中心有限公司 | 抗人cd34抗体、其制备方法及用途 |
-
2008
- 2008-12-03 JP JP2010537235A patent/JP2011505810A/ja not_active Ceased
- 2008-12-03 US US12/746,990 patent/US20100311955A1/en not_active Abandoned
- 2008-12-03 WO PCT/CN2008/001963 patent/WO2009079922A1/zh not_active Ceased
- 2008-12-03 EP EP08865354A patent/EP2233501B1/en not_active Not-in-force
- 2008-12-03 BR BRPI0821211-2A patent/BRPI0821211A2/pt not_active IP Right Cessation
- 2008-12-03 CA CA2708407A patent/CA2708407A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011505810A5 (https=) | ||
| JP7366897B2 (ja) | 抗ｔｉｇｉｔ抗体 | |
| JP6856610B2 (ja) | ヘテロ二量体免疫グロブリンの精製 | |
| CN108283001B (zh) | 包含κ和λ轻链的抗原结合多肽构建体及其用途 | |
| CN110256569B (zh) | 具有交换结合区取向的双重可变区抗体样结合蛋白 | |
| CN109517065B (zh) | Il-18结合分子 | |
| JP7257971B6 (ja) | 抗ｃｄ４０抗体、その抗原結合フラグメント、およびその医学的使用 | |
| WO2021057978A1 (zh) | 抗vhh域抗体及其用途 | |
| JP2023509212A (ja) | 新型ポリペプチド複合物 | |
| JP2020505017A5 (https=) | ||
| JP2020524510A5 (https=) | ||
| JP2011505810A (ja) | ヒト化抗ヒトｃｄ３４抗体、その調製方法および使用 | |
| JP2011527899A5 (https=) | ||
| JP2020515277A5 (https=) | ||
| JP7836033B2 (ja) | Ｇｐｒｃ５ｄ抗体及びその応用 | |
| CN109721656B (zh) | 靶向rankl的治疗性抗体 | |
| WO2023025315A1 (zh) | 抗b7-h3抗体、其制备方法及用途 | |
| JP2022516351A (ja) | 抗ｔｉｇｉｔ抗体 | |
| JP7412440B2 (ja) | アビド結合多重特異性抗体を作製する方法 | |
| CN113912728B (zh) | 降低抗人白介素-33单克隆抗体生产中宿主细胞蛋白含量的亲和纯化方法 | |
| JP2020525432A (ja) | 非対称ヘテロ二量体ＦＣ−ＳＣＦＶ融合抗ＧＬＯＢＯ Ｈおよび抗ＣＤ３二重特異的抗体およびがん療法（ｃａｎｅｒ ｔｈｅｒａｐｙ）におけるその使用 | |
| CN116528909A (zh) | 抗肿瘤坏死因子受体(tnfr2)抗体及其用途 | |
| JP2022547135A (ja) | 増強されたプロテインｌ捕捉動的結合容量を有する二重特異性抗原結合ポリペプチドの精製方法 | |
| CN101817881B (zh) | Fmu-epcam-4 f6单克隆抗体的轻链和重链可变区 | |
| KR20200024828A (ko) | 안정화된 키메라 fabs |